Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04026230
Title Impact of Atorvastatin on Prostate Cancer Progression During ADT (ESTO2)
Acronym ESTO2
Recruitment Recruiting
Gender male
Phase Phase III
Variant Requirements No
Sponsors Tampere University Hospital
Indications
Therapies
Age Groups: adult | senior
Covered Countries NOR | FIN | EST | DNK

Facility Status City State Zip Country Details
Herlev and Gentofte Hospital NOT_YET_RECRUITING Herlev Denmark Details
Tartu University Hospital RECRUITING Tartu Estonia Details
Helsinki University Hospital, Department of Urology RECRUITING Helsinki Finland Details
Central Finland central hospital RECRUITING Jyväskylä Finland Details
Kuopio University Hospital, Department of Urology NOT_YET_RECRUITING Kuopio Finland Details
Seinäjoki Central Hospital, Department of Surgery RECRUITING Seinäjoki Finland Details
Tampere University Hospital RECRUITING Tampere Finland Details
Turku University Hospital RECRUITING Turku Finland Details
The Hospital of Telemark RECRUITING Skien Norway Details
The Hospital of Vestfold RECRUITING Tønsberg Norway Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field